CE
CERo Therapeutics Holdings, Inc.
CEROW · OTC
$0.00 +182.35% (+$0.00)
1M +117.65%
Market Cap $101.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 388.91%
Asset turnover 0.00x
ROA 547.09%
Debt
0 /100
High Current ratio 0.30x
Debt/Equity N/A
Debt/Assets N/A
Stability
1 /100
Unstable Beta 0.16x
Profitable years 0
EPS volatility 7,214.36%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CEROW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher Ehrlich
Employees
8
Headquarters
South San Francisco
Upcoming events
02 DEC
Earnings
Upcoming earnings report